16. A basal plus bolus correction insulin regimen (a strategy using multiple doses of long- and short-acting insulins) is a reasonable option for correcting hyperglycemia in hospitalized, non-critically ill diabetic patients. [IIa, B] The use of sliding-scale insulin in the inpatient hospital setting is discouraged. [III, C]. The gene discussed is INS; the disease is Hyperglycemia.